亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

山東省鄆城匯諾化工有限公司  

醫藥中間體、農藥中間體、催化劑

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:侯女士
  • 電話:0530-7139066
  • 郵件:1824997916@qq.com
  • 傳真:0530-6870009
  • QQ:1824997916
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 對叔丁基芐胺,39895-55-1山東匯諾面向全國大量供應
對叔丁基芐胺,39895-55-1山東匯諾面向全國大量供應
單價 10000.00 / 噸對比
銷量 暫無
發貨 山東菏澤市付款后3天內
庫存 99噸起訂1噸
品牌 對叔丁基芐胺,39895-55-1,匯諾
型號 39895-55-1
規格 對叔丁基芐胺,39895-55-1
過期 長期有效
更新 2020-09-03 13:36
 
詳細信息
對叔丁基芐胺 
別名:4-叔丁基芐胺,4-叔-丁基芐胺,對叔丁基芐胺,39895-55-1
CAS:39895-55-1
英文:(4-tert-butylphenyl)methanamine
外觀:對叔丁基芐胺是無色至黃色透明液體
類別: 醫藥中間體
含量:≥99%
分子式:C11H17N
分子量:163.26
沸點:235-236℃;閃點:107℃;密度:0.93
包裝:180kg/桶
用途:對叔丁基芐胺是一種合成有機中間體
我們愿與國內外廠家建立合作關系實現雙贏,共同發展。歡迎新老客戶蒞臨參觀指導,洽談業務。

©2025 山東省鄆城匯諾化工有限公司 版權所有   技術支持:化工網   訪問量:50541  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |